Neurogenesis persists in the adult rat rostral forebrain subventricular zone (SVZ) and is stimulated by status epilepticus (SE). More caudal SVZ (cSVZ) neural progenitors migrate to the hippocampus after ischemic injury and contribute to CA1 pyramidal cell regeneration. Because SE also damages the hippocampus, we examined the effects of SE on cSVZ precursors. SE was induced in adult rats with pilocarpine, and cell proliferation in cSVZ and hippocampus was examined by bromodeoxyuridine (BrdU) and retroviral reporter labeling. Neural precursors were assayed by immunostaining for specfic markers between 1 and 35 days after SE. BrdU-positive cells labeled prior to SE markedly increased in numbers within 1-2 weeks in the cSVZ and infracallosal region, but not in the corpus callosum. Doublecortin-, polysialic acid neural cell adhesion molecule-, and TUC-4 (TOAD/Ulip/CRMP family-4)-immunostained cells with migrating morphology increased with a similar time course after SE and extended from the cSVZ to CA1 and CA3 regions. Retroviral reporters injected into the cSVZ of controls showed labeled cells with oligodendroglial morphology located in the cSVZ and corpus callosum; when injected 2 days prior to SE, many more reporter-labeled cells appeared several weeks later and were located in the cSVZ, corpus callosum, and hippocampus. Labeled cells showed glial morphologies and expressed astrocyte or oligodendrocyte markers. Neither BrdU-nor retroviral reporter-labeled cells coexpressed neuronal markers in controls or pilocarpine-treated rats. These results indicate that SE increases cSVZ gliogenesis and attracts newly generated glia to regions of hippocampal damage. Further study of seizure-induced gliogenesis may provide insight into mechanisms of adult neural progenitor regulation and epileptogenesis. V V C 2006 Wiley-Liss, Inc.
INTRODUCTION
Neural progenitors persist in the adult mammalian forebrain subventricular zone (SVZ) and hippocampal dentate gyrus (DG) (Altman and Das, 1965; Altman, 1969; Kaplan and Hinds, 1977; Bayer, 1983; Cameron et al., 1993; Lois and Alvarez-Buylla, 1994; Kuhn et al., 1996; Eriksson et al., 1998; Gould et al., 1998; Kornac and Rakic, 1999) . In the adult rodent, SVZ progenitors generate olfactory bulb interneurons and DG progenitors give rise predominantly to dentate granule cells (Bayer, 1983; Cameron et al., 1993; Kuhn et al., 1996; Luskin, 1998) . Less well studied are neural progenitors in the SVZ that develop into glia. These progenitors extend to the caudal SVZ (cSVZ) of the lateral ventricle and in neonatal or juvenile rodents give rise to white matter astrocytes and oligodendrocytes, or their precursors (Levison et al., 1993 (Levison et al., , 1999 . The capacity for SVZ progenitors to generate glia in the adult is uncertain (Picard-Riera et al., 2004) .
Seizure-induced injury increases neurogenesis in both the DG and SVZ-olfactory bulb pathway (Parent et al., 1997 (Parent et al., , 1998 (Parent et al., , 2002 Bengzon et al., 1997; Gray and Sundstrom, 1998; Scott et al., 1998) . Prolonged seizures also induce the ectopic migration of neuroblasts to damaged regions (Parent et al., 1997 (Parent et al., , 2002a (Parent et al., , 2005 . Rostral SVZ neuronal precursors that migrate aberrantly after seizures or other acute brain injuries may have reparative potential (Arvidsson et al., 2002; Parent et al., 2002a,b) . Evidence suggests, however, that seizure-induced ectopic migration of dentate granule cell progenitors leads to aberrant neuronal integration that may be detrimental (Parent et al., 1997 (Parent et al., , 2005 Scharfman et al., 2000; Dashtipour et al., 2001) .
Recent data indicate that neural progenitors in the adult rodent cSVZ migrate to regions of ischemic hippocampal damage and replace injured CA1 pyramidal neurons. Nakatomi and colleagues showed that delayed hippocampal CA1 pyramidal cell death induced by transient global ischemia in adult rat leads to replacement of damaged CA1 pyramidal neurons by endogenous neural progenitors (Nakatomi et al., 2002) . At least a portion of these progenitors arose from the cSVZ (referred to as the posterior periventricle region). Brief intraventricular infusion of growth factors in the first week after stroke markedly increased regeneration and behavioral recovery, although others have found significant CA1 regeneration even in the absence of growth factor treatment (Bendel et al., 2005) . These studies suggest that ischemic brain injury stimulates neurogenesis in otherwise dormant regions of the adult rodent brain, and raise the possibility that other forms of brain injury may also activate hippocampal self-repair mechanisms.
Prolonged seizures in the pilocarpine model of mesial temporal lobe epilepsy (TLE) (mTLE) increase rostral SVZ neurogenesis and cause hippocampal pyra-midal cell death (Turski et al., 1983; Parent et al., 2002a) . We reasoned that, like ischemic injury, status epilepticus (SE)-induced hippocampal damage may lead to a low-level of hippocampal pyramidal cell regeneration from cSVZ progenitors. We, therefore, examined the effect of pilocarpine-induced SE on cSVZ progenitors in adult rat. Bromodeoxyuridine (BrdU) labeling and retroviral reporter injections into the cSVZ were used to examine cell proliferation and migration. The phenotypes of newborn cells were determined by immunofluorescence double labeling and confocal microscopy. We found that SE increased cSVZ cell proliferation and induced ectopic migration of cSVZ neural progenitors to the injured hippocampus. The newborn cells, however, did not replace damaged pyramidal cells but instead differentiated exclusively into glia.
METHODS

Pilocarpine-Induced SE
Young adult, male Sprague Dawley rats (200-240 g) were pretreated with injections of atropine methylbromide (5 mg/kg, i.p.; Sigma, St. Louis, MO) and 15 min later were given pilocarpine hydrochloride (340 mg/kg, i.p.; Sigma) to induce SE. If seizure activity did not start within an hour after the initial pilocarpine injection, an additional dose of 170 mg/kg was given. Seizures were monitored behaviorally and then terminated after 2 h of focal convulsive SE (head and forelimb clonus) with diazepam (10 mg/kg, i.p.; Elkins-Sinn, Cherry Hill, NJ); additional doses of 5 mg/kg diazepam were given at 45-60 min intervals if subtle seizure activity persisted. Control rats were treated identically except that 0.9% sodium chloride solution was substituted for pilocarpine. All procedures were approved by research oversight committees for the use and care of animals at the University of California, San Francisco and the University of Michigan Medical Centers.
BrdU Labeling and Tissue Processing
BrdU labeling was used to identify proliferating (S phase) cells and follow their disposition over time. BrdU (50 mg/kg; Roche, Indianapolis, IN) was administered intraperitoneally (i.p.) using two different protocols: (1) twice, 6 h apart, on day 7 after saline or pilocarpine treatment (n ¼ 3-4/time point for each group) and animals were perfused 2, 7, 14, or 28 days later (9, 14, 21, or 35 days after SE); or (2) twice, 6 h apart, on day 2 prior to pilocarpine or saline treatment (n ¼ 3/time point for each group), and rats were killed 3, 6, 9, 12, or 16 days later (1, 4, 7, 10, or 14 days after SE). With the latter labeling regimen, BrdU incorporates into constitutively dividing cells that are subsequently exposed to the prolonged seizure episode. The influence of pilocarpine-induced SE on DGC neurogenesis using this ''pre-seizure'' BrdU labeling regimen has been described previously (Parent et al., 1999) . Rats received an overdose of pentobarbital sodium (Abbott Laboratories, North Chicago, IL) and were transcardially perfused with phosphatebuffered saline (PBS) followed by 4% paraformaldehyde (pH, 7.4; 360 ml). After postfixation in situ overnight, brains were removed, washed once in PBS, cryoprotected with 30% sucrose in PBS, and frozen in powdered dry ice. Brains were sectioned coronally at 40 lm thickness through the entire rostral-caudal extent of the hippocampal formation.
Retroviral Reporter Injections
Proliferating cells in the cSVZ were labeled specifically by injection of replication-incompetent retrovirus carrying nuclear localization signal b-galactosidase (nls-b-gal, GPGnlsLZ; a gift of Richard Mulligan, Harvard University, Cambridge, MA) or enhanced green fluorescent protein (LNIT-GFP; a gift of Fred Gage, The Salk Institute, La Jolla, CA) reporters. Vesicular stomatitis virus G protein pseudotyped retrovirus was generated from 293GPG producer cells, the supernatant was collected, and the virus was concentrated and titered as described previously (Ory et al., 1996) . Animals were anesthetized with i.p. ketamine (70 mg/kg) and xylazine (8 mg/kg), positioned in a stereotactic frame (Kopf Instruments, Tujunga, CA), and 1-1.5 ll of concentrated (10 8 -10 9 cfu) virus stock (with 80 lg/ml polybrene) was injected stereotactically into the cSVZ at the level of the dorsal hippocampus over 5 min. Injection coordinates relative to bregma were 4.1 mm posterior and 5.0 mm lateral, at a depth of 3.1 mm from the brain surface. Injection sites were confirmed in processed tissue by visualizing the needle track. Adult rats were injected 2 days before pilocarpine (n ¼ 7) or saline (n ¼ 5) treatment, and animals were killed 11, 16, or 23 days after retrovirus injection (9, 14, or 21 days after SE). Two additional rats injected with LNIT-GFP that received pilocarpine but did not experience convulsions were killed 16 days after retrovirus injection and considered as controls.
Immunohistochemistry and Confocal Microscopy
Diaminobenzidine peroxidase immunohistochemistry was performed on free-floating tissue sections or slides as described previously (Parent et al., 1997 (Parent et al., , 2002a . For BrdU immunostaining, DNA was denatured by incubating tissue sections in 2 N HCl for 30 min at 378C followed by a 10 min wash in 0.1 M borate solution, pH 8.5. Tissue was incubated for 24-48 h in primary antibody at 48C; antibody dilutions used were: 1:1,000 for BrdU (mouse monoclonal; Boehringer Mannheim, Indianapolis, IN), 1:5,000 for doublecortin (DCx; rabbit polyclonal, a gift of C. Walsh, Harvard University); and 1:5,000-10,000 for TUC-4 (TOAD/ULIP/CRMP-4; rabbit polyclonal, a gift of S. Hockfield, MA Institute of Technology). Single and double-label immunofluorescence histochemistry was done according to published methods (Parent et al., 2002a) . Primary antibody dilutions used were: 1:200 for BrdU (rat monoclonal; Accurate Chemical, Westbury, NY); 1:500 for polysialylated neural cell adhesion molecule (PSA-NCAM; mouse IgM 5A5 clone; Developmental Studies Hybridoma Bank, University of Iowa); 1:10,000 for TUC-4; 1:200 for neuron-specific b-tubulin (TuJ1; mouse monoclonal; Babco, Berkely, CA); 1:1,000 for neuronal nuclear protein (NeuN; mouse monoclonal; Chemicon, Temecula, CA); 1:1,000 for myelin basic protein (MBP; rat monoclonal, Chemi-con); 1:500 for microtubule-associated protein 2 (MAP2; mouse monoclonal; Sigma), 1:200-500 for glial fibrillary acidic protein (GFAP; rat monoclonal, a gift of V. Lee, University of Pennsylvania; or rabbit polyclonal, Sigma); 1:2,000 for neurofilament-L (NF-L, gift of V. Lee); and 1:1,000 for b-gal (rabbit polyclonal; 5@-3 Prime, Boulder, CO). Secondary antibodies for immunofluorescence were goat antirat IgG conjugated to fluorescein isothiocyanate (FITC), Cy-5 or Texas Red, goat antimouse IgG conjugated to FITC, Texas Red or Alexa-594 (Molecular Probes), goat antirabbit IgG conjugated to FITC or Texas Red, and goat antimouse IgM conjugated to Texas Red (all species cross-adsorbed and from Jackson Immunoresearch Laboratories, West Grove, PA unless otherwise noted) at 1:400 dilutions. Tissue was incubated in secondary antibody overnight at 48C. For double-label immunofluorescence using rat anti-BrdU and a second primary antibody, free-floating sections were incubated in the second primary antibody for 24 h at 48C, washed with Trisbuffered saline (TBS) (0.15 M NaCl, 0.1 M Tris-HCl, pH 7.6) for 45 min, postfixed in 4% PFA for 20 min, rinsed 3 times with TBS, and denatured with 2 N HCl as described above. After TBS washes and blocking, sections were incubated in rat antiBrdU antibody and the second primary antibody for another 24 h at 48C. Double-or triple-label immunofluorescence, images were obtained using a BioRad MRC 1024 (Hercules, CA) or Zeiss LSM 510 (Oberkochen, Germany) confocal laser microscope as z-series stacks (1.0 lm optical thickness), visualized with National Institutes of Health (NIH) Image version 1.61 software, and transferred to Adobe Photoshop for color merging (Adobe Systems, Mountain View, CA).
Image Analysis and Statistical Comparisons
Light microscopic images of coronal brain sections were acquired using a Leica DMIRB (Heidelberg, Germany) inverted microscope and SPOT-RT (SPOT Diagnostic Instruments, Sterling Heights, MI) digital camera. BrdU-immunoreactive cells in digitized images captured under a 203 objective were counted using a counting grid with the examiner blinded to experimental condition. One region of interest included the cSVZ adjacent to the caudal most aspect of the lateral ventricle at dorsal hippocampal levels and extending medially, covering the infracallosal region including the alveus and part of stratum oriens of CA1. The other region of interest included the midline corpus callosum. Counts were made from 3 rats/group using 5-6 sections (10-12 dentate gyri) spaced at least 240 lm apart over the dorsal hippocampus. Statistical comparisons between groups for each region were made using a two-tailed Student's t-test. Analyses were performed with StatView software (Abacus Concepts, Berkeley, CA) and the significance level was set at P < 0.05. For semiquantitative analysis of DCx expression in the cSVZ (Table 1) , the magnitude of immunoreactivity was examined under 103 and 203 objectives and graded on a 5-point scale: -, no immunoreactivity; þ, minimal immunoreactivity; þþ, moderate immunoreactivity in the cSVZ extending several cell layers in thickness infracallosally; þþþ, strong immunoreactivity in the cSVZ and infracallosal region with some cells extending into CA1 and CA3; þþþþ, very strong immunoreactivity in the cSVZ and infracallosal region with many cells extending into CA1 and CA3.
RESULTS
SE Increases cSVZ Neural Progenitor Cell Proliferation
We previously found that pilcocarpine-induced SE increases neurogenesis in the DG and rostral forebrain SVZ (Parent et al., 1997 (Parent et al., , 1999 (Parent et al., , 2002a . During these studies, we also noted that SE markedly increases cell proliferation in non-neurogenic regions of the hippocampus (Fig. 1A, B) . We, therefore, sought to determine whether any of the newly generated hippocampal cells arose from the nearby cSVZ germinative zone, and to determine their phenotypes. The initial strategy involved labeling constitutively proliferating cells with BrdU prior to seizure induction to avoid identifying mainly reactive glia induced to proliferate by injury. A similar strategy showed that constitutively dividing cells in the DG subgranular zone are stimulated by SE to generate increased numbers of progeny (Parent et al., 1999) .
We administered BrdU 2 days prior to pilocarpine treatment and examined BrdU labeling at different time points after SE. In the cSVZ and infracallosal region adjacent to the dorsal hippocampus, BrdU-immunoreactive cell numbers were not increased 1 day after SE (3 days after BrdU administration) when compared with that of saline-treated controls (data not shown). By 4-7 days after SE, however, cSVZ and infracallosal BrdU labeling increased and peaked at 10-14 days after pilocarpine treatment (Fig. 1C-F) . Quantification of cSVZ BrdU-immunoreactive cells in animals 10 days after saline or pilocarpine treatment (12 days after BrdU administration) showed significantly greater numbers in pilocarpinetreated rats (cells [mean 6 SEM]: pilocarpine: 38.7 6 6.0; saline: 12.9 6 0.4; P ¼ 0.01). Because the corpus callosum also contains proliferating cells that are putative oligodendrocyte progenitors (Gensert and Goldman,1996) , we quantified BrdU-positive cell numbers in this region for comparison and Fig. 2 ) was scored by a blinded observer as: none (-); minimal (þ); moderate immunoreactivity in the cSVZ extending to several cell layers thickness infracallosally (þþ); strong immunoreactivity in the cSVZ and infracallosal region with some cells extending into CA1 and CA3 (þþþ); or very strong immunoreactivity in the cSVZ and infracallosal region with many cells extending into CA1 and CA3 (þþþþ). Scores are means from 4-5 per group (Numbers). d SE, days after status epilepticus.
found no difference between pilocarpine-and saline-treated rats at 10 days after treatment (cells [mean 6 SEM]: pilocarpine: 29.2 6 6.0; saline: 16.8 6 0.4; P ¼ 0.14). These findings indicate that cells proliferating prior to SE accumulate specifically in the cSVZ and infracallosal hippocampal regions, but not in the corpus callosum, another area containing proliferating cells.
cSVZ Precursors Migrate to the Hippocampus After SE
Many BrdU-positive cells found in the cSVZ after SE had fusiform-shaped nuclei, suggestive of migrating cells, and extended toward the CA1 and CA3 pyramidal cell regions (Fig. 1E) . The finding of more BrdU positive cells in the hippocampus with longer time intervals after the preseizure BrdU administration (data not shown) also suggested migration to the injured hippocampus. To examine whether the cSVZ precursors were migrating, and to begin to determine their phenotypes, we labeled cells with DCx, TUC-4, and PSA-NCAM, markers typically expressed by migrating neuroblasts (Gleeson et al., 1999; Nacher et al., 2000 Nacher et al., , 2001 Parent et al., 2002a Parent et al., ,b, 2005 . Immunoreactivity for these markers was minimal in the cSVZ and infracallosal region of controls ( Fig.  2A , C, E, Table 1 , and data not shown). By contrast, cSVZ and infracallosal expression of DCx, TUC-4, and PSA-NCAM increased markedly after SE (Fig. 2B, D , F, G and Table 1 ). Many of the cells exhibited a bipolar ''migratory'' morphology with leading and lagging processes, and appeared to extend from the cSVZ/infracallosal region to the injured hippocampus (Fig. 2B, D) . SE stimulated the expression of DCx in the cSVZ with a time course similar to that found for BrdU (Table 1) .
We suspected that the immature cells putatively migrating from the cSVZ to the hippocampus were neuroblasts based on their expression of DCx, TUC-4, and PSA-NCAM. Consistent with a progenitor phenotype of the TUC-4-, DCx-, and PSA-NCAM-immunoreactive cells, double-labeling for BrdU and TUC-4 or PSA-NCAM showed colocalization in many cells at 10 days after pilocarpine treatment (Fig. 2F-F@ and data not shown). However, when we double-labeled with antibodies for these markers and for the neuron-specific markers b-tubulin (TuJ1) or MAP2 (a,b and c isoforms), no cellular colocalization was apparent (data not shown). This finding is unlike our prior results that showed stroke-induced migration of DCx-immunoreactive cells from the rostral SVZ to the striatum, which strongly express b-tubulin (TuJ1) or MAP2 (Parent et al., 2002b) , and findings of cSVZ neuronal progenitors migrating to the ischemia-damaged hippocampus (Nakatomi et al., 2002) . Most of the cells also did not express glial fibrillary acidic protein (Fig. 2G) .
We next sought further evidence regarding the possibility that the cSVZ cells migrate to the hippocampus. Retrovirus carrying a GFP or nls-b-gal reporter was injected into the cSVZ 2 days prior to pilocarpine or saline treatment, and animals were killed 11, 16, or 23 days later (9, 14, or 21 days after SE). In controls, GFP-immunoreactive cells were restricted to the cSVZ or corpus callosum and displayed oligodendrocyte or oligodendrocyte progenitor morphologies (Fig. 3A) . This finding is consistent with prior reports using similar retroviral reporter injections into the SVZ of juvenile rats (Levison et al., 1993) . After pilocarpine-induced SE, many more cells were labeled and they appeared in the hippocampus in addition to the cSVZ and corpus callosum (Fig. 3B, C) . No GFP-labeled cells in controls or pilocarpine treated rats appeared in cortex or other subcortical regions. Taken together with the data described earlier, these results provide strong evidence that cSVZ progenitors migrate to the injured hippocampus after pilocarpine-induced SE. Hippocampal and cSVZ cell proliferation after pilocarpine-induced SE. Coronal sections from control (A, C) and pilocarpine-treated adult rats (B, D-F) immunostained for BrdU. A, B: A representative animal given BrdU 7 days after pilocarpine and killed 14 days later shows much more BrdU labeling in the DG and CA1 region (B) when compared with that in a salinetreated control (A). C-F: cSVZ BrdU labeling in a saline-treated control (C) and pilocarpine-treated rats (D-F) given BrdU 2 days prior to pilocarpine or saline and killed 10 (C-E) or 14 (F) d later (12 or 16 days after BrdU). cSVZ and infracallosal BrdU labeling (arrows) increased markedly in the pilocarpine-treated rats. Note also the fusiform nuclear shape of infracallosal cells that incorporated BrdU 12 days earlier (inset in E) when compared with the rounder shape in the CA1 region when BrdU was given 7 days after SE and the animal killed 14 days later (inset in B). CC, corpus callosum; Dentate Gyrus, DG; LV, lateral ventricle; CA, cornu ammonis. Scale bar = 400 lm (A, B) ; 100 lm (C, D, F); 200 lm (E); and 50 lm (insets).
cSVZ-Derived Precursors Differentiate Exclusively Into Glia in the Injured Hippocampus
The phenotypes of cSVZ cells migrating to the hippocampus after SE were studied next. Because the retroviral-GFP reporter fills the cell bodies and processes, we carefully examined cell morphology as an initial assessment of the different cell phenotypes. Cells expressing the GFP reporter all exhibited glial morphologies, both astrocytic and oligodendrocytic (Figs. 3 and 4A, E) . No neuronal-appearing GFP-labeled cells were found. We then double or triple labeled for GFP or b-gal and glial or neuronal markers. GFP-positive cells in controls and pilocarpine-treated rats coexpressed MBP and GFAP in the corpus callosum and hippocampus ( Fig. 4A-H) . Double-labeling for bgal and the neuronal markers NeuN, NF-L, MAP2, or neuronspecific b-tubulin showed no colocalization of signal in cSVZ, corpus callosum, or hippocampal cells expressing the retroviral Cells labeled by cSVZ retroviral reporter injections migrate to the hippocampus after SE. GFP+ cells in coronal sections from rats 21 days after saline (A) or pilocarpine treatment (B, C). LNIT-GFP retroviral reporter was injected into the right cSVZ 2 days prior to treatment. In the control, all labeled cells are in the corpus callosum and have oligodendrocytic morphology (inset in A). Prolonged seizures increase the number of GFP-labeled cells and induce cell migration to the hippocampus as well as corpus callosum (B, C). Labeled cells have both astrocytic and oligodendroglial morphologies after SE. Panel C shows a higher magnification view of hippocampal cells in a different section from the same rat as in B. Medial is to the left and dorsal to the top in all panels. CC, corpus callosum; CA, cornu ammonis; LV, lateral ventricle. Scale bar = 150 lm (A, B) ; 40 lm (C); 20 lm (inset in A).
nls-b-gal reporter (Fig. 4I-L) . The findings therefore show that cSVZ cells induced to migrate to the injured hippocampus after SE differentiate into glia but not neurons.
DISCUSSION
The present results indicate that the cSVZ is a third germinative zone in the adult, in addition to the rostral SVZ and DG, that is activated by pilocarpine-induced SE. Similar to the DG and SVZ-olfactory bulb pathway (Parent et al., 1997 (Parent et al., , 2002a (Parent et al., , 2005 , prolonged seizures increase cSVZ cell proliferation and alter neural progenitor migration. Instead of migrating exclusively into the corpus callosum as was found in control adult rats, however, a portion of the cSVZ progenitors at dorsal hippocampal levels was diverted to the injured hippocampus (Fig. 5) . Unlike neural progenitors in the rostral SVZ and DG that differentiate nearly exclusively into neurons in the intact brain or after SE, cSVZ precursors that migrate to the corpus callosum and hippocampus differentiate into glia. Neuronal replacement, therefore, appears to be absent in the hippocampal pyramidal cell layer after seizure-induced injury in the adult.
Why should cSVZ progenitors give rise to neurons after transient global ischemia but only glia after SE? The most likely explanation is that the modes of cell death are different after these types of injuries. The ischemia models in which CA1 pyramidal cell regeneration is found cause a delayed apoptotic pyramidal cell death (Nakatomi et al., 2002; Bendel et al., 2005) . Pilocarpine-induced SE, on the other hand, involves a mixed form of cell death that includes a significant necrotic component (Fujikawa et al., 1999 (Fujikawa et al., , 2002 Weise et al., 2005) . Macklis and colleagues have shown that transplanted or endogenous neural progenitors in adult mouse brain give rise to cortical pyramidal neurons after a toxin-induced apoptotic cell death but not after necrosis caused by kainic acid injection (Snyder et al., 1997; Magavi et al., 2000) . These differences may relate to inhibitory factors generated after necrosis, or absence of necessary growth or survival factors in necrotic envi- Model of cSVZ neural progenitor behavior after seizure-induced hippocampal injury. Adult neural progenitors proliferate in the cSVZ (1) and normally migrate into the corpus callosum (CC) to form oligodendrocytes or oligodendrocyte progenitors (2). After SE, cSVZ progenitors migrate to the injured hippocampus and differentiate into glial cells (3). SE simultaneously increases dentate granule cell neurogenesis in the dentate hilus (h) and granule cell layer (dgc).
ronments that are stimulated only by apoptosis . Another possibility is that ischemic injury upregulates the expression of a more ''neurogenic'' repertoire of growth or differentiation factors than does pilocarpine-induced SE.
Our findings also highlight the lack of specificity of putative ''neuronally-specified'' progenitor markers such as DCx or TUC-4 (Jin et al., 2004; Couillard-Despres et al., 2005) , as has been recognized previously for TUC-4/CRMP-4 (Nacher et al., 2000) . Prior investigations of the DG, rostral SVZ-olfactory bulb pathway and striatum after seizure-or focal ischemiainduced injury showed that DCx, TUC-4 and PSA-NCAM expression reliably identified immature neurons that also were immunoreactive for neuron-specific b-tubulin and MAP2 (Parent et al., 1997 (Parent et al., , 1999 (Parent et al., , 2002a . Progenitors in the cSVZ that express DCx, TUC-4, and PSA-NCAM after SE, however, are glial lineage cells. Studies of SVZ progenitors in the intact neonatal and juvenile rat suggest that many of these progenitors migrate into subcortical white matter and cortex where they give rise mainly to oligodendroglial precursors, and the remainder to astrocytes (Levison et al., 1993 (Levison et al., , 1999 Gensert and Goldman, 1996) . Further investigation is necessary to determine the specific classes of glial progenitors labeled by putative ''neuroblast'' markers in the adult, and whether the same SVZ progenitors give rise to both neurons and glia.
We cannot exclude the possibility that some progeny of cSVZ cells dividing after SE, at time points other than those used in the present study for BrdU or retroviral reporter administration, gave rise to neurons. DCX-, TUC-4-, or PSA-NCAM-immunoreactive cells destined to become neurons may fail to survive in the injured hippocampus. This possibility is unlikely given that the cells did not express the immature neuron-specific markers class III b-tubulin or MAP2c, and because we found no double-labeled neurons in the pyramidal cell layer in animals injected with BrdU 7 days after SE and killed 2 weeks later (data not shown). Certainly the known lack of hippocampal regeneration after pilocarpine-induced SE excludes a significant degree of neurogenesis with long-term survival of newly formed neurons. Our findings after cSVZ retroviral reporter injections also suggest that potential newborn neurons, if any, do not arise from the constitutively dividing cells in the cSVZ, although our retroviral reporters would not have labeled quiescent cells that could be recruited after seizure-induced injury. Nonetheless, these results indicate that the majority, if not all, of the cells recruited from the cSVZ to sites of SEinduced hippocampal damage are glial progenitors.
The signals that lead to aberrant cSVZ glial progenitor migration and the effects of ectopic gliogenesis in the epileptic hippocampus are unknown. Seizures upregulate a number of growth factors that have been shown to influence glial progenitor migration, such as basic fibroblast growth factor and vascular endothelial growth factor (Faber-Elman et al., 1996; Holland and Varmus, 1998; de Castro and Bribián, 2005; Hagihara et al., 2005) . Various axon guidance, cell adhesion, and extracellular matrix molecules known to stimulate glial progenitor migration might be involved as well (de Castro and Bribián, 2005; Wang et al., 2005) . The result of ectopic gliogenesis in the injured hippocampus is even less clear. Although they may contribute to repair, recent work suggests that immature astrocytes may promote an epileptic phenotype. Two groups have identified astrocytes with immature features in the sclerotic CA1 region of human hippocampi resected to treat intractable mTLE but not in nonsclerotic hippocampi (Hinterkeuser et al., 2000; Kivi et al., 2000) . These glia possess barium-insensitive potassium channels typical of immature glia. The potassium channels buffer potassium poorly such that, unlike those in mature astrocytes, they may lead to seizure generation in the setting of excessive neuronal depolarization. Although speculative, it is possible that the immature glia arise from the cSVZ during epileptogenesis and remain immature or continue to accumulate because of recurrent seizures. A better understanding of mechanisms that regulate neural stem cells in the postnatal brain may therefore lead to novel treatments that modulate progenitors to block epileptogenesis and promote neural repair.
